Q4 2020 Holdings
Filed 2021-02-16 | 60 holdings | $851.9M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Amarin Corp PLCA | SPONS ADR NEW | 023111206 | $78.0M | 15,943,915 | 9.2% |
| United Therapeutics Corp del(UTHR)A | COM | 91307C102 | $69.6M | 458,636 | 8.2% |
| Alexion Pharmaceuticals Inc(ALXN)A | COM | 015351109 | $58.8M | 376,200 | 6.9% |
| TG Therapeutics Inc(TGTX)A | COM | 88322Q108 | $44.9M | 863,851 | 5.3% |
| Astrazeneca PLC(AZN)A | SPONSORED ADR | 046353108 | $42.6M | 852,431 | 5.0% |
| Horizon Therapeutics PUB LA | SHS | G46188101 | $38.8M | 530,976 | 4.6% |
| Fate Therapeutics Inc(FATE)A | COM | 31189P102 | $36.3M | 399,499 | 4.3% |
| Glaxosmithkline PLCA | SPONSORED ADR | 37733W105 | $35.2M | 946,581 | 4.1% |
| Ascendis Pharma A/S(ASND)A | SPONSORED ADR | 04351P101 | $31.2M | 187,043 | 3.7% |
| Catalent Inc(CTLTEUR)A | COM | 148806102 | $29.1M | 279,503 | 3.4% |
| Envista Holdings Corporation(NVST)A | COM | 29415F104 | $29.1M | 861,355 | 3.4% |
| Danaher Corporation(DHR)A | COM | 235851102 | $28.1M | 126,330 | 3.3% |
| Teva Pharmaceutical Inds LTD(TEVA)A | SPONSORED ADS | 881624209 | $26.5M | 2,748,250 | 3.1% |
| Avantor Inc(AVTR)A | COM | 05352A100 | $25.9M | 920,650 | 3.0% |
| Sarepta Therapeutics Inc(SRPT)A | COM | 803607100 | $23.6M | 138,644 | 2.8% |
| Anthem Inc(ELV)A | COM | 036752103 | $21.1M | 65,771 | 2.5% |
| Zogenix IncA | COM NEW | 98978L204 | $18.2M | 909,708 | 2.1% |
| Qiagen NV(QGEN)A | SHS NEW | N72482123 | $17.8M | 336,862 | 2.1% |
| Ensign Group Inc(ENSG)A | COM | 29358P101 | $15.2M | 208,470 | 1.8% |
| Deciphera Pharmaceuticals in(DCPHEUR)A | COM | 24344T101 | $14.1M | 246,240 | 1.6% |
| Glaxosmithkline PLCCallA | SPONSORED ADR | 37733W105 | $13.0M | 352,600 | 1.5% |
| Intra Cellular Therapies Inc(ITCIEUR)A | COM | 46116X101 | $11.3M | 356,235 | 1.3% |
| Taro Pharmaceutical Inds LTDA | SHS | M8737E108 | $11.2M | 152,256 | 1.3% |
| Heska Corp(HSKAEUR)A | COM RESTRC NEW | 42805E306 | $11.1M | 76,166 | 1.3% |
| Kadmon Hldgs Inc(KDMN)A | COM | 48283N106 | $10.0M | 2,408,885 | 1.2% |
| Biohaven Pharmactl Hldg Co L(BHVN)A | COM | G11196105 | $8.9M | 103,764 | 1.0% |
| Magellan Health IncA | COM NEW | 559079207 | $8.7M | 104,700 | 1.0% |
| Rite AID Corp(RADEUR)A | COM | 767754872 | $8.4M | 532,004 | 1.0% |
| Aurinia Pharmaceuticals Inc(AUPH)A | COM | 05156V102 | $8.4M | 604,368 | 1.0% |
| Seres Therapeutics Inc(MCRB1EUR)A | COM | 81750R102 | $8.2M | 334,049 | 1.0% |
| Quidel CorpA | COM | 74838J101 | $7.3M | 40,583 | 0.9% |
| Amarin Corp PLCCallA | SPONS ADR NEW | 023111206 | $6.3M | 1,285,400 | 0.7% |
| Affimed N VA | COM | N01045108 | $5.6M | 964,707 | 0.7% |
| Amneal Pharmaceuticals Inc(AMRX)A | COM STK CL A | 03168L105 | $5.4M | 1,178,153 | 0.6% |
| Oxford Immunotec Global PLCA | ORD SHS | G6855A103 | $5.4M | 307,742 | 0.6% |
| Altimmune Inc(ALT)A | COM NEW | 02155H200 | $4.3M | 380,000 | 0.5% |
| Biocryst Pharmaceuticals Inc(BCRX)A | COM | 09058V103 | $3.7M | 491,852 | 0.4% |
| Five Prime Therapeutics Inc(FPRX)A | COM | 33830X104 | $3.6M | 209,155 | 0.4% |
| Sanofi(SNY)A | SPONSORED ADR | 80105N105 | $3.3M | 68,138 | 0.4% |
| HCA Healthcare Inc(HCA)A | COM | 40412C101 | $2.8M | 16,754 | 0.3% |
| Prothena Corp PLC(PRTA)A | SHS | G72800108 | $2.4M | 203,328 | 0.3% |
| Sesen BIO IncA | COM | 817763105 | $2.1M | 1,559,824 | 0.2% |
| Anaptysbio Inc(ANAB)A | COM | 032724106 | $1.9M | 88,334 | 0.2% |
| Surmodics Inc(SU6)A | COM | 868873100 | $1.8M | 41,299 | 0.2% |
| Oncternal Therapeutics IncA | COM | 68236P107 | $1.7M | 344,090 | 0.2% |
| Otonomy IncA | COM | 68906L105 | $1.6M | 253,283 | 0.2% |
| Autolus Therapeutics PLC(AUTL)A | SPON ADS | 05280R100 | $1.4M | 154,981 | 0.2% |
| Concert Pharmaceuticals Inc(CNCEEUR)A | COM | 206022105 | $1.3M | 103,829 | 0.2% |
| Catabasis Pharmaceuticals in(CATBEUR)A | COM NEW | 14875P206 | $1.1M | 522,042 | 0.1% |
| Exagen Inc(XGN)A | COM | 30068X103 | $1.1M | 81,603 | 0.1% |